⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8557939 | 1.00 | — | — | |
| SCHEMBL10953408 | 0.91 | NFKB1 (0.41) | — | |
| SCHEMBL22872687 | 0.91 | NFKB1 (0.41) | — | |
| SCHEMBL22267421 | 0.88 | DNM1 (0.44) | — | |
| SCHEMBL20467587 | 0.88 | DNM1 (0.44) | — | |
| SCHEMBL28437674 | 0.88 | NFKB1 (0.35) | — | |
| SCHEMBL830074 | 0.87 | NFKB1 (0.40) | — | |
| Ammonia Solution, Strong SCHEMBL23581245 | 0.84 | NFKB1 (0.38) | — | |
| SCHEMBL31333176 | 0.81 | GABRR1 (0.36) | — | |
| SCHEMBL16297584 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11253717-B2 | Aesthetic method of biological structure treatment by magnetic field | BTL HEALTHCARE TECHNOLOGIES A.S. (CZ) | 2022-02-22 | — | — | US | disclosed |
| WO-2021026185-A1 | INDOLE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF | NEW YORK UNIVERSITY (US) | 2021-02-11 | — | — | WO | disclosed |
| WO-2020081840-A1 | METHODS OF TREATING CANCER WITH ARYL HYDROCARBON RECEPTOR ANTAGONISTS | Magenta Therapeutics Inc. (US) | 2020-04-23 | — | — | WO | disclosed |
| EP-3508530-A1 | THERMOPLASTIC RESIN COMPOSITION, AND LAMINATE USING SAME | Riken Technos Corporation (JP) | 2019-07-10 | — | — | EP | disclosed |
| US-10259846-B2 | Bouvardin derivatives and therapeutic uses thereof | THE REGENTS OF THE UNIVERSITY OF COLORADO (US) | 2019-04-16 | — | — | US | disclosed |
| US-20170342082-A1 | [8-(PHENYLSULFONYL)-3,8-DIAZABICYCLO[3.2.1]OCT-3-YL](1H-1,2,3-TRIAZOL-4-YL)METHANONES | Bayer Pharma AG (DE) | 2017-11-30 | — | — | US | disclosed |
| US-20170218025-A1 | BOUVARDIN DERIVATIVES AND THERAPEUTIC USES THEREOF | SUVICA, INC. | 2017-08-03 | — | — | US | disclosed |